Healthcare Providers and Services
Company Overview of Brigham and Women's Hospital
Brigham and Women's Hospital, an academic medical center, operates inpatient and outpatient facilities, clinics, primary care health centers, and diagnostic and treatment technologies and research laboratories. It provides clinical, translational, bench, and population-based research studies, including nurses health studies, physicians health studies, and the women's health initiatives. The company also offers cardiovascular medicine, neurology, neurosurgery, newborn medicine, obstetrics and gynecology, orthopedic surgery, pathology, psychiatry, radiation oncology, radiology, surgery, women’s health, arthritis and rheumatic disorders, orthopedics, pain management, dermatology, emergency medi...
75 Francis Street
Boston, MA 02115
Founded in 1980
Key Executives for Brigham and Women's Hospital
Chief Operating Officer and Executive Vice President
Senior Vice President of Communication and Public Affairs
Director of Public Affairs
Compensation as of Fiscal Year 2015.
Brigham and Women's Hospital Key Developments
Brigham and Women's Hospital Names David W. Bates as Chief Innovation Officer
Feb 7 15
David W. Bates, MD, MSc, has been named Senior Vice President and Chief Innovation Officer at Brigham and Women's Hospital (BWH), effective immediately. In this new leadership position, Bates, an internationally renowned expert in patient safety, will foster a culture of innovation and the establishment of infrastructure to support it across the institution. Bates, who previously served as the Chief Quality Officer at BWH, will focus on identifying opportunities to drive transformative change at BWH, with the goal of translating inventions, discoveries and new ideas into services and products that benefit patients and improve the delivery of care. He will also serve as executive sponsor of the Brigham Innovation Hub (iHub), a catalyst of innovation across the hospital. Bates will continue in his role as chief of the Division of General Medicine and Primary Care at BWH. Bates is also a professor of medicine at Harvard Medical School and a professor of Health Policy and Management at the Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness. He also serves as medical director of Clinical and Quality Analysis for Partners Healthcare.
Brigham and Women's Hospital Names Paul J. Anderson as Chief Academic Officer and Senior Vice President of Research
Jan 26 15
Paul J. Anderson has been named chief academic officer and senior vice president of Research for Brigham and Women's Hospital (BWH), effective immediately. This is new position, created earlier this year to bring a senior leadership focus to the core values of research and education. Anderson, a senior physician in the Division of Rheumatology, Immunology and Allergy and the K. Frank Austen professor of Medicine at Harvard Medical School, has been serving in this role on an interim basis since June. Under Anderson's leadership, BWH will focus on the development and implementation of an innovative, creative and research and education strategic plan; proactive and collaborative relationships within BWH and
across Partners HealthCare, as well with as industry leaders; and fostering relationships with both private and
public research funding entities. Anderson will oversee the activities of the Brigham Research Institute and will serve as executive leader as the hospital develops the Brigham Education Institute.
NanoString Technologies, Inc. Collaborates with Brigham and Women's Hospital to Accelerate Translation of Genomic Discoveries into Clinical Diagnostics in Oncology
Oct 6 14
NanoString Technologies, Inc. announced that it has signed a multi-year, multi-investigator research collaboration with Brigham and Women's Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics. Using NanoString's Elements reagents, assays will be developed to detect gene expression, copy number variations, and fusions from a diverse range of tumor samples. NanoString's nCounter(R) Analysis System is an automated and easy-to-use platform that utilizes a novel digital barcoding chemistry to deliver high precision multiplexed assays across a number of important research applications. The research collaboration will enable the researchers at Brigham and Women's Hospital to evaluate and analyze a repository of patient derived tumor tissues for identification of gene signatures and gene expression profiles that typify a specific tumor type. This knowledge is expected to fuel the development of validated diagnostic tests with potential to vastly improve clinical decisions involved in treatment of cancer patients. Under the terms of the agreement, NanoString retains the right to license diagnostic content developed within the scope of the collaboration.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|